The Center for Pediatric Clinical Effectiveness at Children's Hospital of Philadelphia is ushering in the fall with a call for applications to its Pilot Grant Program. The program aims to support CHOP investigators who are interested in conducting studies designed to gather evidence about novel strategies that could shift current research or a clinical practice paradigm.
Sometimes half is better than whole. That's the idea behind a new multicenter study that Children's Hospital of Philadelphia is participating in to compare a five-day (short) course of antibiotic therapy with a 10-day (standard) course of therapy to treat community-acquired pneumonia (CAP) in children. Pneumonia is a lung infection that is the leading infectious cause of death in children
Welcome back to our regular roundup of research news from Children's Hospital of Philadelphia! Now that we are bringing you these updates biweekly, we have an even richer collection of stories to share. This week's highlights include an important update for clinicians to recognize that hypertension risk may be underdiagnosed in children; research on the ongoing needs of childhood cancer
One of the biggest looming threats to humanity's future is a monster of our own inadvertent creation. This isn't a summer superhero movie plot. It's the frightening reality of antibiotic-resistant strains of bacteria and other microbes, which arise over time as more bugs are exposed to more drugs, and evolve resistance to their effects.
The American Academy of Otolaryngology-Head and Neck Surgery published a guideline in 2011 recommending that “clinicians should not routinely administer or prescribe perioperative antibiotics to children undergoing tonsillectomies.”